NEKTAR THERAPEUTICS
SEC Filing List
NKTR CIK: 0000906709
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | OLSHAN FROME WOLOSKY LLP /fa | 05/15/2026 | |||
| 8-K | Current report filing | Nektar Therapeutics | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/08/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Nektar Therapeutics | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/08/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Nektar Therapeutics | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/08/2026 | |
| 8-K | Current report filing | Nektar Therapeutics | EdgarAgents LLC /fa | 05/07/2026 | |
| SCHEDULE 13G/A | 05/06/2026 | ||||
| DEF 14A | Definitive proxy statements | Nektar Therapeutics | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| ARS | Annual report to security holders | Nektar Therapeutics | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Nektar Therapeutics | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Nektar Therapeutics | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |
| No record found. | |||||
| Load More | |||||
